Re-immunotherapy with Nivolumab plus Ipilimumab in Advanced NSCLC Patients Previously Treated with Anti-PD-(L)1 Antibody
JOURNAL OF THORACIC ONCOLOGY（2023）
关键词
cytotoxic T-lymphocyte-associated protein-4,programmed death-1,immune checkpoint inhibitor
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要